Subscribe
shutterstock_492675739_mdart10
MDart10 / Shutterstock.com
10 May 2022BiotechnologyAlex Baldwin

L’Oreal’s anti-wrinkle cosmetics infringe, claims GlycoBioSciences

Canadian pharmaceutical company  GlycoBioSciences has sued cosmetics giant  L’Oreal, alleging that the French company’s anti-wrinkle products containing hyaluronic acid infringe two patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
L’Oreal prevails in anti-aging treatment clash
12 January 2023   Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.
Americas
L’Oreal wins infringement suit over ‘indefinite’ patents
22 April 2021   L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.
Americas
Allergan sues cosmetics companies for trademark infringement
7 April 2017   Allergan has filed a complaint against cosmetics companies Dermavita and Dima and PR company KBC Media for trademark infringement and false advertising.


Editor's picks

Smart ringleader: Could Ōura’s market dominance be under threat?
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025

Editor's picks

Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
2 September 2025
Europe
UPC sees rising small molecule litigation with Pfizer in the hot seat
29 August 2025
Europe
Astellas win strengthens blockbuster drug's European position
20 August 2025
Europe
Four firms reach highest tier in WIPR’s 2025 Global Trade Secrets Rankings
18 August 2025
Americas
Latham steps into dispute over $6bn treatment, replacing Kirkland
13 August 2025

More on this story

article
L’Oreal prevails in anti-aging treatment clash
12 January 2023   Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.
Americas
L’Oreal wins infringement suit over ‘indefinite’ patents
22 April 2021   L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.
Americas
Allergan sues cosmetics companies for trademark infringement
7 April 2017   Allergan has filed a complaint against cosmetics companies Dermavita and Dima and PR company KBC Media for trademark infringement and false advertising.

More on this story

article
L’Oreal prevails in anti-aging treatment clash
12 January 2023   Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.
Americas
L’Oreal wins infringement suit over ‘indefinite’ patents
22 April 2021   L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.
Americas
Allergan sues cosmetics companies for trademark infringement
7 April 2017   Allergan has filed a complaint against cosmetics companies Dermavita and Dima and PR company KBC Media for trademark infringement and false advertising.

More features

Buchalter brings in new partner to head up medtech
Trump’s march-in rights threat: Why pharma is rethinking collaborations
UK gets new IP minister following cabinet reshuffle
Barnes & Thornburg reveals five new IP leaders
Former PTAB judge joins Sterne Kessler
GSK escalates mRNA COVID-19 vaccine dispute
Smart ringleader: Could Ōura’s market dominance be under threat?
The flaw that landed Sanofi a win in the rare disease space